Funding

New Funding Opportunities

Notice Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses (R21 Clinical Trial Optional)
Notice Number
Post Date October 17, 2024
Expiration Date November 17, 2025
Notice Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses (R01 Clinical Trial Optional)
Notice Number
Post Date October 17, 2024
Expiration Date November 6, 2025

Past Funding Opportunities

Notice

 Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRCs) (U54 Clinical Trial Optional)
Notice Number

Notice

 Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R01 Clinical Trial Optional)
Notice Number

Notice

 Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R21 Clinical Trial Optional)
Notice Number

Notice

 Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R01 Clinical Trials Not Allowed)
Notice Number

Notice

 Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R21 Clinical Trial Not Allowed)
Notice Number

Notice

 Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRCs) (U54 Basic Experimental Studies Involving Humans Allowed)
Notice Number
Notice Data Management and Coordinating Center (DMCC) for the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRC) (U24 Basic Experimental Studies with Humans Required)
Notice Number
Notice Clinical Validation of a Candidate Biomarker for Neurological Disease (U01 Clinical Trial Optional)
Notice Number
Notice Analytical Validation of a Candidate Biomarker for Neurological Disease (U01 Clinical Trial Optional)
Notice Number
Notice Analytical Validation of a Candidate Biomarker for Neurological Disease (U44 Clinical Trial Optional)
Notice Number
Notice Clinical Validation of a Candidate Biomarker for Neurological Disease (U44 Clinical Trial Optional)
Notice Number

This page last reviewed on January 21, 2025